Page last updated: 2024-10-27

2,5-dihydroxybenzoic acid and Osteoporosis

2,5-dihydroxybenzoic acid has been researched along with Osteoporosis in 1 studies

2,5-dihydroxybenzoic acid: RN given refers to parent cpd; a oxidative product of saligenin
2,5-dihydroxybenzoic acid : A dihydroxybenzoic acid having the two hydroxy groups at the 2- and 5-positions.

Osteoporosis: Reduction of bone mass without alteration in the composition of bone, leading to fractures. Primary osteoporosis can be of two major types: postmenopausal osteoporosis (OSTEOPOROSIS, POSTMENOPAUSAL) and age-related or senile osteoporosis.

Research Excerpts

ExcerptRelevanceReference
"Osteoporosis is a disease characterized by low bone mass, most commonly caused by an increase in bone resorption that is not matched by sufficient bone formation."1.48Locally delivered ethyl-2,5-dihydroxybenzoate using 3D printed bone implant for promotion of bone regeneration in a osteoporotic animal model. ( Han, JJ; Kim, D; Kim, J; Kim, MS; Koo, MA; Kwon, BJ; Lee, MH; Park, JC; Seon, GM, 2018)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kwon, BJ1
Seon, GM1
Lee, MH1
Koo, MA1
Kim, MS1
Kim, D2
Han, JJ1
Kim, J1
Park, JC1

Other Studies

1 other study available for 2,5-dihydroxybenzoic acid and Osteoporosis

ArticleYear
Locally delivered ethyl-2,5-dihydroxybenzoate using 3D printed bone implant for promotion of bone regeneration in a osteoporotic animal model.
    European cells & materials, 2018, 01-12, Volume: 35

    Topics: Animals; Bone and Bones; Bone Density; Bone Regeneration; Cell Differentiation; Coated Materials, Bi

2018